A Medicine Company | Eli Lilly and Company
WEBLearn the latest information on the availability of Lilly diabetes and obesity medicines. Learn how to protect yourself from counterfeit Mounjaro ® and Zepbound ® and unapproved tirzepatide products.
Current Medicines | Medicines | Eli Lilly and Company
WEBFor more than 145 years, we have worked tirelessly to develop and deliver trusted medicines and diagnostics that meet real needs. Our growing portfolio of medicines includes treatments in the areas of bone muscle joint, cancer, cardiovascular, diabetes, endocrine, immunology, neuroscience and obesity. The product information on this …
About Us | Eli Lilly and Company
WEBWe’re a medicine company turning science into healing to make life better for people around the world. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing science to solve some of the world's most significant health challenges.
Find Your Career with Eli Lilly | Lilly Careers
WEBJoin Our Talent Community. Find your place at Lilly with Lilly Careers. For more than a century, we have united caring with discovery to make life better, join us today.
Contact Us | Eli Lilly and Company
WEBIf you are having trouble paying for a prescription for your Lilly medicine, learn more below about solutions that may work for you. Please call us. We want to help. NOTE: For more information about Lilly's COVID-19 therapies authorized for emergency use, contact the Lilly COVID Hotline at 1-855-LillyC19 (1-855-545-5921).
Key Facts | Who We Are | Eli Lilly and Company
WEBJun 30, 2024 — Key Facts. For nearly 150 years, we’ve made significant and game-changing progress on our mission to make life for people around the world. We’ve remained headquartered in Indianapolis, Indiana, since our founding on May 10, 1876, but our employees now work in countries around the world.
News Release - Eli Lilly and Company
WEBDec 15, 2021 — As it has for nearly 100 years, Lilly continues to work to transform diabetes care through insulin innovation. Lilly 's novel weekly insulin is on track to progress to phase 3 studies in 2022, and the company is advancing a new generation of insulin medicines with its pre-clinical efforts in glucose-sensing insulin.
Investors | Eli Lilly and Company
WEBSep 13, 2024 — The Investor Relations website contains information about Eli Lilly and Company's business for stockholders, potential investors, and financial analysts.
Home | Lilly UK - Eli Lilly and Company
WEBOur commitment to making life better goes beyond the medicines we make – it’s at the very heart of our business.
News Release - Eli Lilly and Company
WEBApr 22, 2024 — INDIANAPOLIS and LINCOLNSHIRE, Ill., April 22, 2024 – Eli Lilly and Company (NYSE: LLY) and Nexus Pharmaceuticals, LLC today announced a definitive agreement for Lilly to acquire a manufacturing facility from Nexus, a leading sterile manufacturer in the pharmaceutical industry.